Tremelimumab-Induced Graves Hyperthyroidism

Gan, EH; Mitchell, AL; Plummer, R; Pearce, S; Perros, P

Gan, EH (reprint author), Int Ctr Life, Inst Med Genet, Ctr Pkwy, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.

EUROPEAN THYROID JOURNAL, 2017; 6 (3): 167

Abstract

Tremelimumab and ipilimumab are monoclonal antibodies directed against the extracellular domain of cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4......

Full Text Link